New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
06:35 EDTWX, ILMNWuXi PharmaTech purchases Illumina HiSeq X Ten Sequencing System
Illumina (LMN) and WuXi PharmaTech (WX) announced that the WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system. This new investment will enable WuXi’s clinical genomic services to expand from the current target panel, exome, and transcriptome scale sequencing to population genome scale sequencing. It puts the world’s most advanced gene sequencing capability in the hands of the leading pharmaceutical R&D services company in the Asia Pacific region. The WuXi Genome Center meets international clinical standards and is the only CLIA-certified clinical genomics lab in China. In addition to offering sequencing services, WuXi’s genomics lab also provides assay development, validation, and testing services.
News For WX;ILMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
05:33 EDTWXWuXi PharmaTech downgraded to Hold from Buy at Jefferies
Jefferies downgraded WuXi PharmaTech to Hold with a $38 price target saying upcoming margin pressure is not priced into shares or reflected in consensus estimates.
November 19, 2014
06:10 EDTILMNIllumina, USAID and Broad Institute partner to combat ebola in West Africa
Illumina, the U.S. Agency for International Development and the Broad Institute of MIT and Harvard, have entered into a public-private partnership to help combat the Ebola epidemic in West Africa with aid for those on the ground who are fighting the spread of the virus. The partnership will train local and outbreak-deployed personnel to sequence viral genomes from the outbreak, and will extend surveillance operations, as well as equip facilities in West Africa with state-of-the-art genome sequencing technology.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use